24 November 2025
Kropz Plc
("Kropz" or the "Company")
Trading Update
Kropz Plc (AIM: KRPZ), an emerging African phosphate producer and developer, announces a trading update for the period to 30 September 2025 and that Kropz Elandsfontein (Pty) Ltd ("Elandsfontein")
Trading Update
Elandsfontein produced 87,496 tonnes of phosphate concentrate in Q3 2025, representing a 17% increase compared to the previous quarter. Sales for the period totalled 72,408 tonnes, a 28% increase quarter on quarter.
The quarter closed with a record production month in September 2025, during which 34,070 tonnes of phosphate concentrate were produced.
The mine remains in its trial production phase.
For further information visit www.kropz.com or contact:
| Kropz Plc | Via Tavistock |
| Louis Loubser (CEO) | +44 (0) 207 920 3150 |
|
|
|
| Grant Thornton UK LLP | Nominated Adviser |
| Samantha Harrison Harrison Clarke Ciara Donnelly
| +44 (0) 20 7383 5100 |
|
| |
| Hannam & Partners | Broker |
| Andrew Chubb | +44 (0) 20 7907 8500 |
|
|
|
| Tavistock | Financial PR & IR (UK) |
| Nick Elwes Jos Simson
| +44 (0) 207 920 3150 kropz@tavistock.co.uk |
|
|
|
| R&A Strategic Communications | PR (South Africa) |
| Charmane Russell Marion Brower | +27 (0) 11 880 3924 charmane@rasc.co.za marion@rasc.co.za
|
The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. The information is disclosed in accordance with the Company's obligations under Article 17 of the UK MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.
-ENDS-
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
